scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1007307755 |
P356 | DOI | 10.1038/ONC.2009.409 |
P932 | PMC publication ID | 2829108 |
P698 | PubMed publication ID | 19935720 |
P5875 | ResearchGate publication ID | 40029023 |
P2093 | author name string | Z Lin | |
P Yin | |||
M O'Halloran | |||
S E Bulun | |||
S Reierstad | |||
G M Mutlu | |||
E K Pearson | |||
V J S Coon | |||
P2860 | cites work | Role of estrogen receptor beta in estrogen action | Q24290841 |
From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response | Q24313831 | ||
Identification of ERF-1 as a member of the AP2 transcription factor family | Q24314887 | ||
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ | Q25257848 | ||
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta | Q28215162 | ||
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 | Q28260929 | ||
The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein | Q33561391 | ||
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells. | Q34522572 | ||
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 | ||
A glance at adenosine receptors: novel target for antitumor therapy | Q35556102 | ||
Adenosine regulation of alveolar fluid clearance | Q35676784 | ||
A1 adenosine receptors play an essential role in protecting the embryo against hypoxia | Q35834361 | ||
Estrogen-receptor biology: continuing progress and therapeutic implications | Q36065443 | ||
Are aromatase inhibitors superior to antiestrogens? | Q36110134 | ||
Estrogen signaling and prediction of endocrine therapy | Q36307432 | ||
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer | Q37288929 | ||
Current controversies in extended adjuvant endocrine therapy for early breast cancer | Q37289138 | ||
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer | Q38301651 | ||
AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinoma | Q38306274 | ||
Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells. | Q40095142 | ||
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. | Q40198514 | ||
Stable knockdown of estrogen receptor alpha by vector-based RNA interference suppresses proliferation and enhances apoptosis in breast cancer cells | Q40270203 | ||
RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis | Q40350122 | ||
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. | Q40470094 | ||
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines | Q40483284 | ||
Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes | Q40498615 | ||
An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation | Q40626058 | ||
Cancer statistics, 1999. | Q40817780 | ||
The 3'-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover | Q40864729 | ||
PD 116,948, a highly selective A1 adenosine receptor antagonist | Q41479175 | ||
Sensitization of visceral afferents to bradykinin in rat jejunum in vitro | Q42480612 | ||
Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases. | Q42522011 | ||
Endogenous activation of adenosine A1 receptors promotes post-ischemic electrocortical burst suppression. | Q44540086 | ||
Early renal post-ischaemic tissue damage and dysfunction with contribution of A1-adenosine receptor activation in rat. | Q46126305 | ||
Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer | Q46610637 | ||
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury | Q46668123 | ||
Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor | Q57255422 | ||
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells | Q60568779 | ||
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D) | Q70239986 | ||
Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture | Q70306908 | ||
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells | Q71124075 | ||
The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells | Q77835923 | ||
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes | Q83297557 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1114-1122 | |
P577 | publication date | 2009-11-23 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer | |
P478 | volume | 29 |
Q39148961 | Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. |
Q36191587 | Aromatase, breast cancer and obesity: a complex interaction |
Q30981105 | Combined Analysis of SNP Array Data Identifies Novel CNV Candidates and Pathways in Ependymoma and Mesothelioma |
Q49412232 | Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line |
Q24319134 | Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells |
Q37775889 | Extracellular adenosine triphosphate and adenosine in cancer. |
Q38870205 | Extracellular purines, purinergic receptors and tumor growth. |
Q55163381 | Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats. |
Q34038901 | Immunity, inflammation and cancer: a leading role for adenosine |
Q90317840 | Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer |
Q39224357 | Role of adenosine signaling in the pathogenesis of breast cancer. |
Q57460030 | Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model |
Q93062525 | Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function |
Q37721517 | The Role of Adenosine Signaling in Headache: A Review |
Q37626856 | The complex nature of oestrogen signalling in breast cancer: enemy or ally? |
Q38744576 | The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line |
Q98185640 | Tumorigenesis and Progression As A Consequence of Hypoxic TME:A Prospective View upon Breast Cancer Therapeutic Targets |
Search more.